Skip to content

Comparison the effect of EMLA Cream and lidocaine spray with rhythmic breathing on pain intensity due to arterial-venous needles in hemodialysis patients

Comparison the effect of EMLA Cream and lidocaine spray with rhythmic breathing on pain intensity due to arterial-venous needles in hemodialysis patients

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220512054826N1
Enrollment
88
Registered
2022-05-23
Start date
2022-06-22
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe pain of needle insertion into venous arterial fistula in hemodialysis patients. Pain from vascular prosthetic devices, implants and grafts, initial encounter

Interventions

Intervention 1: Intervention group: In the EMLA Cream group, in the first session, patients are given the necessary explanations related to the research, and at the end of the first hemodialysis sessi
After cleaning the skin of the area, two puffs of lidocaine spray (20 mg) are sprayed by the researcher from a distance of 5 cm on the skin surface where the needle enters. Du

Sponsors

Gonabad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: A history of at least 3 months of hemodialysis through fistula Age over 18 years Alert lack of difficulty in accessing arteries lack of neuropathic disorders and peripheral vascular diseases Not receiving painkillers or sedatives at least 6 hours before hemodialysis lack of severe pain in other areas Minimum literacy lack of Recognized mental disability lack of addiction or dependence on painkillers Lack of treat with sulfonamides, nitrates and phenobarbital lack of history of Fauvism

Exclusion criteria

Exclusion criteria: The patient's unwillingness to continue collaborating in the research Unsuccessful cannulation in the first attempt and repeated insertion of the needle into the skin Creating a critical life-threatening situation

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Before and after the intervention. Method of measurement: Visual Analog Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Gholizadeh

Gonabad University of Medical Sciences

Mohammadgholizadeh762700@gmail.com+98 51 5722 3513

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026